KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $35.8 million.

  • Globus Medical's Capital Expenditures fell 1462.39% to $35.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.6 million, marking a year-over-year increase of 1187.63%. This contributed to the annual value of $115.4 million for FY2024, which is 4746.79% up from last year.
  • Globus Medical's Capital Expenditures amounted to $35.8 million in Q3 2025, which was down 1462.39% from $46.6 million recorded in Q2 2025.
  • Globus Medical's Capital Expenditures' 5-year high stood at $46.6 million during Q2 2025, with a 5-year trough of $8.4 million in Q2 2021.
  • In the last 5 years, Globus Medical's Capital Expenditures had a median value of $20.0 million in 2022 and averaged $23.3 million.
  • As far as peak fluctuations go, Globus Medical's Capital Expenditures crashed by 3872.9% in 2021, and later skyrocketed by 18324.59% in 2022.
  • Over the past 5 years, Globus Medical's Capital Expenditures (Quarter) stood at $17.0 million in 2021, then rose by 7.6% to $18.3 million in 2022, then increased by 24.76% to $22.9 million in 2023, then fell by 25.22% to $17.1 million in 2024, then skyrocketed by 109.32% to $35.8 million in 2025.
  • Its last three reported values are $35.8 million in Q3 2025, $46.6 million for Q2 2025, and $36.1 million during Q1 2025.